Illumina Cash on Hand 2006-2020 | ILMN

Illumina cash on hand from 2006 to 2020. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Illumina cash on hand for the quarter ending September 30, 2020 was $3.324B, a 4.99% increase year-over-year.
  • Illumina cash on hand for 2019 was $3.414B, a 2.79% decline from 2018.
  • Illumina cash on hand for 2018 was $3.512B, a 63.73% increase from 2017.
  • Illumina cash on hand for 2017 was $2.145B, a 37.59% increase from 2016.
Illumina Annual Cash on Hand
(Millions of US $)
2019 $3,414
2018 $3,512
2017 $2,145
2016 $1,559
2015 $1,386
2014 $1,338
2013 $1,166
2012 $1,350
2011 $1,190
2010 $894
2009 $694
2008 $640
2007 $386
2006 $131
2005 $51
Illumina Quarterly Cash on Hand
(Millions of US $)
2020-09-30 $3,324
2020-06-30 $3,268
2020-03-31 $3,332
2019-12-31 $3,414
2019-09-30 $3,166
2019-06-30 $3,173
2019-03-31 $3,615
2018-12-31 $3,512
2018-09-30 $3,389
2018-06-30 $2,512
2018-03-31 $2,373
2017-12-31 $2,145
2017-09-30 $2,041
2017-06-30 $1,893
2017-03-31 $1,778
2016-12-31 $1,559
2016-09-30 $1,536
2016-06-30 $1,425
2016-03-31 $1,343
2015-12-31 $1,386
2015-09-30 $1,439
2015-06-30 $1,510
2015-03-31 $1,366
2014-12-31 $1,338
2014-09-30 $1,271
2014-06-30 $1,103
2014-03-31 $1,092
2013-12-31 $1,166
2013-09-30 $1,028
2013-06-30 $1,129
2013-03-31 $1,067
2012-12-31 $1,350
2012-09-30 $1,233
2012-06-30 $1,302
2012-03-31 $1,266
2011-12-31 $1,190
2011-09-30 $1,132
2011-06-30 $1,234
2011-03-31 $1,135
2010-12-31 $894
2010-09-30 $807
2010-06-30 $785
2010-03-31 $748
2009-12-31 $694
2009-09-30 $760
2009-06-30 $735
2009-03-31 $673
2008-12-31 $640
2008-09-30 $650
2008-06-30 $303
2008-03-31 $275
2007-12-31 $386
2007-09-30 $353
2007-06-30 $343
2007-03-31 $327
2006-12-31 $131
2006-09-30 $170
2006-06-30 $157
2006-03-31 $49
2005-12-31 $51
2005-09-30 $50
2005-06-30 $55
2005-03-31 $62
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $47.025B $3.543B
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.192B 10.06
Amgen (AMGN) United States $129.265B 13.51
CSL (CSLLY) Australia $100.321B 0.00
Gilead Sciences (GILD) United States $76.052B 10.11
Moderna (MRNA) United States $60.441B 0.00
Vertex Pharmaceuticals (VRTX) United States $59.224B 27.54
Regeneron Pharmaceuticals (REGN) United States $55.064B 19.53
Biogen (BIIB) United States $36.958B 6.57
Seagen (SGEN) United States $30.708B 81.10
BioNTech SE (BNTX) Germany $28.111B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.723B 10.65
Genmab (GMAB) Denmark $25.307B 29.93
Genmab (GNMSF) Denmark $23.353B 5.38
BeiGene (BGNE) Cayman Islands $23.216B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $18.514B 0.00
Exact Sciences (EXAS) United States $18.210B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.122B 61.14
Horizon Therapeutics Public (HZNP) Ireland $15.545B 22.22
Alnylam Pharmaceuticals (ALNY) United States $15.093B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.286B 94.82
ARGENX SE-ADR (ARGX) Netherlands $13.483B 0.00
Guardant Health (GH) United States $12.109B 0.00
Mirati Therapeutics (MRTX) United States $11.959B 0.00
Bio-Techne Corp (TECH) United States $11.711B 74.89
Sarepta Therapeutics (SRPT) United States $11.116B 0.00
QIAGEN (QGEN) Netherlands $10.991B 24.75
Repligen (RGEN) United States $9.980B 141.54
Ascendis Pharma (ASND) Denmark $9.013B 0.00
ACADIA Pharmaceuticals (ACAD) United States $9.008B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.967B 0.00
Novavax (NVAX) United States $8.881B 0.00
Galapagos (GLPG) Belgium $8.011B 0.00
Denali Therapeutics (DNLI) United States $7.311B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.236B 0.00
Acceleron Pharma (XLRN) United States $7.114B 0.00
Adaptive Biotechnologies (ADPT) United States $6.595B 0.00
Blueprint Medicines (BPMC) United States $6.023B 19.94
Amicus Therapeutics (FOLD) United States $5.965B 0.00
Exelixis (EXEL) United States $5.944B 39.92
SWEDISH ORP BIO (BIOVF) Sweden $5.355B 14.63
Halozyme Therapeutics (HALO) United States $5.286B 244.38
NeoGenomics (NEO) United States $5.283B 1586.00
Reata Pharmaceuticals (RETA) United States $5.175B 0.00
Fate Therapeutics (FATE) United States $5.101B 0.00
Twist Bioscience (TWST) United States $5.045B 0.00
China Biologic Products (CBPO) China $4.684B 30.35
Emergent Biosolutions (EBS) United States $4.342B 14.25
Vir Biotechnology (VIR) United States $4.061B 0.00
Insmed (INSM) United States $3.974B 0.00
Legend Biotech (LEGN) United States $3.842B 0.00
Arena Pharmaceuticals (ARNA) United States $3.831B 0.00
MorphoSys AG (MOR) Germany $3.682B 133.29
Eidos Therapeutics (EIDX) United States $3.559B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.518B 0.00
Bluebird Bio (BLUE) United States $2.926B 0.00
Alkermes (ALKS) Ireland $2.906B 28.53
Beam Therapeutics (BEAM) United States $2.898B 0.00
Global Blood Therapeutics (GBT) United States $2.837B 0.00
Seres Therapeutics (MCRB) United States $2.519B 0.00
Zymeworks (ZYME) Canada $2.413B 0.00
Intellia Therapeutics (NTLA) United States $2.320B 0.00
Alcobra (ARCT) United States $2.247B 0.00
I-Mab (IMAB) China $2.233B 0.00
PHARMA MAR SA (PHMMF) Spain $2.161B 0.00
Sorrento Therapeutics (SRNE) United States $2.156B 0.00
UniQure (QURE) Netherlands $2.139B 0.00
Viela Bio (VIE) United States $2.102B 0.00
Inovio Pharmaceuticals (INO) United States $2.070B 0.00
Amarin (AMRN) Ireland $1.940B 0.00
Editas Medicine (EDIT) United States $1.907B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Intra-Cellular Therapies (ITCI) United States $1.895B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.800B 0.00
Mesoblast (MESO) Australia $1.770B 0.00
Arcus Biosciences (RCUS) United States $1.768B 0.00
Mersana Therapeutics (MRSN) United States $1.745B 0.00
Scholar Rock Holding (SRRK) United States $1.676B 0.00
NGM Biopharmaceuticals (NGM) United States $1.636B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Revance Therapeutics (RVNC) United States $1.607B 0.00
Zealand Pharma (ZEAL) Denmark $1.533B 0.00
Precigen (PGEN) United States $1.469B 0.00
Sangamo Therapeutics (SGMO) United States $1.413B 0.00
Epizyme (EPZM) United States $1.396B 0.00
Ligand Pharmaceuticals (LGND) United States $1.357B 35.15
Coherus BioSciences (CHRS) United States $1.330B 8.79
Adverum Biotechnologies (ADVM) United States $1.325B 0.00
Myriad Genetics (MYGN) United States $1.319B 0.00
REGENXBIO (RGNX) United States $1.303B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Athenex (ATNX) United States $1.272B 0.00
Genetron Holdings (GTH) China $1.209B 0.00
Cytokineticsorporated (CYTK) United States $1.189B 0.00
Heska (HSKA) United States $1.182B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.172B 0.00
Travere Therapeutics (TVTX) United States $1.171B 0.00
Vericel (VCEL) United States $1.160B 0.00
Northwest Biotherapeutics (NWBO) United States $1.145B 0.00
Codexis (CDXS) United States $1.098B 0.00
Cellectis S.A (CLLS) France $1.078B 0.00
NantKwest (NK) United States $1.040B 0.00
Alector (ALEC) United States $1.039B 0.00
Arvinas (ARVN) United States $0.981B 0.00
Pliant Therapeutics (PLRX) United States $0.976B 0.00
Morphic Holding (MORF) United States $0.976B 0.00
Frequency Therapeutics (FREQ) United States $0.968B 0.00
Castle Biosciences (CSTL) United States $0.947B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.947B 0.00
Protagonist Therapeutics (PTGX) United States $0.924B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.903B 0.00
Celldex Therapeutics (CLDX) United States $0.890B 0.00
Pharming Group (PHGUF) Netherlands $0.889B 20.29
Compugen (CGEN) Israel $0.879B 0.00
Cardiff Oncology (CRDF) United States $0.873B 0.00
VBI Vaccines (VBIV) United States $0.829B 0.00
Kadmon Holdings (KDMN) United States $0.748B 0.00
MiMedx (MDXG) United States $0.745B 0.00
Cara Therapeutics (CARA) United States $0.731B 0.00
Five Prime Therapeutics (FPRX) United States $0.715B 0.00
Albireo Pharma (ALBO) United States $0.710B 0.00
AnaptysBio (ANAB) United States $0.705B 0.00
Agenus (AGEN) United States $0.704B 0.00
MannKind (MNKD) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.668B 33.92
Sutro Biopharma (STRO) United States $0.660B 0.00
Precision BioSciences (DTIL) United States $0.654B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.652B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.638B 0.00
IVERIC Bio (ISEE) United States $0.611B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.600B 0.00
Geron (GERN) United States $0.579B 0.00
Dynavax Technologies (DVAX) United States $0.560B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.548B 0.00
MeiraGTx Holdings (MGTX) United States $0.542B 0.00
Anika Therapeutics (ANIK) United States $0.537B 72.69
Aquinox Pharmaceuticals (NLTX) United States $0.532B 0.00
Avid Bioservices (CDMO) United States $0.516B 0.00
Merus (MRUS) Netherlands $0.498B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.493B 0.00
Cel-Sci (CVM) United States $0.483B 0.00
Prothena (PRTA) Ireland $0.452B 0.00
Forte Biosciences (FBRX) United States $0.451B 0.00
Spero Therapeutics (SPRO) United States $0.451B 0.00
Puma Biotechnology (PBYI) United States $0.447B 0.00
Clovis Oncology (CLVS) United States $0.435B 0.00
UROGEN PHARMA (URGN) United States $0.434B 0.00
WAVE Life Sciences (WVE) Singapore $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
Cue Biopharma (CUE) United States $0.423B 0.00
Innate Pharma S.A (IPHA) France $0.422B 0.00
Kala Pharmaceuticals (KALA) United States $0.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.416B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Affimed (AFMD) Germany $0.407B 0.00
AC Immune SA (ACIU) Switzerland $0.397B 0.00
Trevena (TRVN) United States $0.394B 0.00
Starpharma Holdings (SPHRY) Australia $0.387B 0.00
Arbutus Biopharma (ABUS) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 18.09
Bicycle Therapeutics (BCYC) United Kingdom $0.378B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Athersys (ATHX) United States $0.366B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 9.30
XOMA (XOMA) United States $0.365B 0.00
Selecta Biosciences (SELB) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
CytomX Therapeutics (CTMX) United States $0.348B 0.00
Verastem (VSTM) United States $0.341B 0.00
ChromaDex (CDXC) United States $0.306B 0.00
Kamada (KMDA) Israel $0.302B 14.13
CorMedix Inc (CRMD) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.289B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
NextCure (NXTC) United States $0.279B 0.00
IBio (IBIO) United States $0.271B 0.00
DBV Technologies S.A (DBVT) France $0.269B 0.00
AquaBounty Technologies (AQB) United States $0.261B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Fortress Biotech (FBIO) United States $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.253B 0.00
Aptinyx (APTX) United States $0.251B 0.00
TELA Bio (TELA) United States $0.236B 0.00
Nicox SA (NICXF) France $0.216B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.193B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
Bellus Health (BLU) Canada $0.190B 0.00
Cerecor (CERC) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Aptevo Therapeutics (APVO) United States $0.181B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.180B 0.00
Theratechnologies (THTX) Canada $0.177B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Checkpoint Therapeutics (CKPT) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.161B 0.00
SESEN BIO, INC (SESN) United States $0.160B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
VolitionRX (VNRX) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.154B 0.00
Kindred Biosciences (KIN) United States $0.153B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Cocrystal Pharma (COCP) United States $0.148B 0.00
Idera Pharmaceuticals (IDRA) United States $0.146B 0.00
TRACON Pharmaceuticals (TCON) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Exicure (XCUR) United States $0.136B 0.00
Lumos Pharma (LUMO) United States $0.125B 0.00
Protalix BioTherapeutics (PLX) Israel $0.120B 0.00
Orgenesis (ORGS) United States $0.117B 243.00
Gritstone Oncology (GRTS) United States $0.115B 0.00
Applied Genetic Technologies (AGTC) United States $0.115B 0.00
Aytu Bioscience (AYTU) United States $0.113B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.112B 0.00
Cogent Biosciences (COGT) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.105B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
Cyclerion Therapeutics (CYCN) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.097B 0.00
Novogen (KZIA) Australia $0.095B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Curis (CRIS) United States $0.085B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.078B 0.00
Prima BioMed (IMMP) Australia $0.077B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 34.00
MiRagen Therapeutics (MGEN) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Soligenix (SNGX) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.064B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Seelos Therapeutics (SEEL) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Edesa Biotech (EDSA) Canada $0.049B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
ATyr Pharma (LIFE) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Cleveland BioLabs (CBLI) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Titan Pharmaceuticals (TTNP) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Celsion (CLSN) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00